Testing effectiveness (Phase 2)Active Not RecruitingNCT07290413What this trial is testingPhotobiomodulation for the Prevention of Oral MucositisWho this might be right forOral Mucositis Brigham and Women's Hospital 78
Testing effectiveness (Phase 2)Study completedNCT00711035What this trial is testingMost Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)Who this might be right forAdenovirus InfectionEBV Infection Baylor College of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT04151706What this trial is testingCD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CMLWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+2 more Robert Lowsky 7
Early research (Phase 1)Study completedNCT01798004What this trial is testingBusulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk NeuroblastomaWho this might be right forGanglioneuroblastomaStage 1 NeuroblastomaStage 2 Neuroblastoma+5 more Children's Oncology Group 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808112What this trial is testingCSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell TransplantationWho this might be right forGraft -Versus-host-disease Medical College of Wisconsin 72
Testing effectiveness (Phase 2)Study completedNCT01597219What this trial is testingTrial of Haploidentical Stem Cell Transplantation for Haematological CancersWho this might be right forHodgkin's LymphomaNon-Hodgkin's LymphomaAcute Myeloid Leukaemia+6 more University College, London 77
Testing effectiveness (Phase 2)Study completedNCT00582933What this trial is testingPhase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated DonorWho this might be right forLeukemiaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma+1 more Memorial Sloan Kettering Cancer Center 96
Not applicableUnknownNCT01719341What this trial is testingStudy of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic AnaemiaWho this might be right forHaematological MalignanciesAcquired Aplastic Anaemia National University Hospital, Singapore 21
Testing effectiveness (Phase 2)Ended earlyNCT00113646What this trial is testingNon-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic MalignanciesWho this might be right forLymphomaLeukemiaMultiple Myeloma+1 more Massachusetts General Hospital 14
Large-scale testing (Phase 3)Study completedNCT02278887What this trial is testingStudy Comparing TIL to Standard Ipilimumab in Patients With Metastatic MelanomaWho this might be right forMetastatic Melanoma The Netherlands Cancer Institute 168
Testing effectiveness (Phase 2)UnknownNCT00807196What this trial is testingZevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin LymphomaWho this might be right forNon-Hodgkins Lymphoma Maisonneuve-Rosemont Hospital 20
Early research (Phase 1)WithdrawnNCT03531281What this trial is testingHuman Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWho this might be right forHematopoietic and Lymphoid Cell NeoplasmHematopoietic Cell Transplantation Recipient City of Hope Medical Center
Early research (Phase 1)Ended earlyNCT00282425What this trial is testingAllogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic SclerosisWho this might be right forScleroderma Richard Burt, MD 8
Testing effectiveness (Phase 2)WithdrawnNCT00159055What this trial is testingAdoptive Immunotherapy for CMV DiseaseWho this might be right forCMV Disease Hadassah Medical Organization 20
Testing effectiveness (Phase 2)Looking for participantsNCT07249346What this trial is testingDose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell TransplantationWho this might be right forLeukemiaMyelodysplasiaChronic Myelomonocytic Leukemia Hannah Choe, MD 124
Testing effectiveness (Phase 2)Study completedNCT00365287What this trial is testingCombination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerWho this might be right forBreast CancerKidney CancerLeukemia+3 more Masonic Cancer Center, University of Minnesota 148
Testing effectiveness (Phase 2)WithdrawnNCT00024128What this trial is testingPeripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related LymphomaWho this might be right forLymphoma AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Study completedNCT00597714What this trial is testingEfficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell TransplantWho this might be right forHodgkin's DiseaseNon Hodgkin's LymphomaMyeloma+2 more David Rizzieri, MD 264
Testing effectiveness (Phase 2)Study completedNCT00005941What this trial is testingPeripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal CancerWho this might be right forCervical CancerVaginal Cancer Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00001830What this trial is testingDonor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow TransplantsWho this might be right forChronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's Disease+2 more National Cancer Institute (NCI) 110